Koers AstraZeneca Pharma India Limited NSE India S.E.
Aandelen
ASTRAZEN
INE203A01020
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5.335 INR | -3,95% | +1,74% | -3,46% |
Omzet 2022 | 8,06 mld. 96,47 mln. 90,3 mln. | Omzet 2023 | 10,03 mld. 120 mln. 112 mln. | Marktkapitalisatie | 81,18 mld. 972 mln. 910 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 616 mln. 7,38 mln. 6,9 mln. | Nettowinst (verlies) 2023 | 993 mln. 11,89 mln. 11,13 mln. | EV/omzet 2022 | 7,38 x |
Nettoliquiditeiten 2022 | 4,4 mld. 52,66 mln. 49,3 mln. | Nettoliquiditeiten 2023 | 4,93 mld. 59,05 mln. 55,27 mln. | EV/omzet 2023 | 7,6 x |
K/w-verhouding 2022 |
104
x | K/w-verhouding 2023 |
81,8
x | Werknemers | - |
Dividendrendement 2022 |
0,39% | Dividendrendement 2023 |
0,49% | Vrij verhandelbaar | 12,42% |
1 dag | -3,95% | ||
1 week | +1,74% | ||
Lopende maand | +0,13% | ||
1 maand | +0,13% | ||
3 maanden | -15,57% | ||
6 maanden | +13,20% | ||
Lopend jaar | -3,46% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Siva Padmanabhan
CEO | Chief Executive Officer | - | - |
Sanjeev Panchal
CEO | Chief Executive Officer | - | 01-02-03 |
Bhavana Agrawal
DFI | Director of Finance/CFO | - | 01-10-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Revathy Ashok
BRD | Director/Board Member | 65 | 02-12-16 |
Chairman | 67 | 06-12-12 | |
Director/Board Member | 50 | 29-12-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
30-04-24 | 5.335 | -3,95% | 65 392 |
29-04-24 | 5.555 | +2,38% | 17 274 |
26-04-24 | 5.426 | +1,75% | 11 479 |
25-04-24 | 5.332 | +0,90% | 3 817 |
24-04-24 | 5.285 | +0,75% | 2 128 |
uitgestelde koers NSE India S.E., 30 april 2024 om 13:42 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+33,15% | 704 mld. | |
+28,63% | 577 mld. | |
-4,27% | 348 mld. | |
+18,46% | 327 mld. | |
+4,82% | 288 mld. | |
+14,66% | 234 mld. | |
+4,93% | 198 mld. | |
-9,78% | 194 mld. | |
-4,39% | 147 mld. |
- Beurs
- Aandelen
- Koers ASTRAZEN
- Koers ASTRAZEN